Houston, TX, United States of America

John F Reichwein

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Encysive Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John F Reichwein. Retrieved from https://idiyas.com/inventor/john-f-reichwein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: John F. Reichwein: Innovator in Pharmaceutical Processes

Introduction

John F. Reichwein is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing complex chemical compounds. His work is essential for advancing treatments for various medical conditions.

Latest Patents

Reichwein holds a patent for the processes related to the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide. This compound is particularly useful for the treatment of endothelin-mediated disorders. His innovative approach in this area showcases his expertise and dedication to improving healthcare solutions.

Career Highlights

Throughout his career, John F. Reichwein has been associated with Encysive Pharmaceuticals, Inc. His role in the company has allowed him to focus on research and development, contributing to the advancement of pharmaceutical technologies. His patent reflects his commitment to creating effective treatments that can benefit patients.

Collaborations

(Section skipped due to space constraints.)

Conclusion

John F. Reichwein's contributions to pharmaceutical processes highlight his innovative spirit and dedication to improving medical treatments. His work continues to impact the field positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…